University Hospital, Tours
Clinical trials sponsored by University Hospital, Tours, explained in plain language.
-
COVID steroid trial pulled before it even started
Disease control TerminatedThis study was designed to see if corticosteroids (prednisone or hydrocortisone) could help COVID-19 patients who need extra oxygen. It planned to enroll adults with confirmed COVID-19 and pneumonia, using CT scans to identify those likely to benefit. However, the trial was withd…
Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Dad's chest vs. incubator: new trial tests skin-to-skin transfer for tiniest babies
Disease control OngoingThis study tests whether carrying a very preterm baby skin-to-skin on the father's chest from the delivery room to the neonatal intensive care unit (NICU) keeps the baby just as warm as the standard incubator transfer. About 118 babies born before 34 weeks will take part. The mai…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New shoulder implant tested for arthritis and rotator cuff tears
Disease control OngoingThis study is testing a shoulder replacement device called the Medacta Shoulder System in 100 people with shoulder arthritis or rotator cuff tears. The goal is to see how well the implant works after 2 years, focusing on shoulder function, safety, and patient satisfaction. Partic…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Ovarian cancer recurrence detection study pulled before starting
Diagnosis TerminatedThis study was designed to see if a blood test called the ROMA score could find ovarian cancer coming back sooner than the usual CA125 test. The goal was to catch recurrences early, which might allow less invasive surgery and improve quality of life. However, the study was withdr…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
Blood markers could spot hidden skin cancer return
Knowledge-focused OngoingThis study follows 35 people with Merkel cell carcinoma, a rare and aggressive skin cancer, to see if two blood markers (T-antigen antibodies and miR-375) can detect when the cancer comes back. Currently, follow-up relies on physical exams and scans, which may miss early recurren…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
French-Language scale for rare nerve disease put to the test
Knowledge-focused OngoingThis study checks whether a French version of a scale called PLSFRS works well for people with primary lateral sclerosis (PLS), a rare nerve disease. Researchers will ask 80 patients to fill out the questionnaire during routine check-ups every 3 to 6 months. The goal is to see if…
Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Dialysis patients may get safer dosing for common infection drug
Knowledge-focused OngoingThis study looks at how the antibiotic cefazolin behaves in the blood of people on chronic hemodialysis who have catheter infections. Researchers will take blood samples at different times to measure drug levels. The goal is to find the best dose to treat infections while avoidin…
Phase: PHASE4 • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC